Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.
Condition(s):Hidradenitis SuppurativaLast Updated:June 5, 2020Withdrawn
Hide Studies Not Open or Pending
Condition(s):Hidradenitis SuppurativaLast Updated:June 5, 2020Withdrawn
Condition(s):Hidradenitis SuppurativaLast Updated:May 21, 2010Completed
Condition(s):Hidradenitis Suppurativa; Hidradenitis Suppurativa \(HS\); Hidradenitis Suppurativa, Acne InversaLast Updated:March 26, 2024Not yet recruiting
Condition(s):Hidradenitis SuppurativaLast Updated:July 22, 2022Completed
Condition(s):Hidradenitis SuppurativaLast Updated:August 4, 2021Withdrawn
Condition(s):Hidradenitis SuppurativaLast Updated:February 16, 2022Completed
Condition(s):Hidradenitis Suppurativa (HS)Last Updated:January 30, 2024Active, not recruiting
Condition(s):Hidradenitis SuppurativaLast Updated:October 25, 2018Completed
Condition(s):Hidradenitis SuppurativaLast Updated:June 14, 2021Completed
Condition(s):Hidradenitis SuppurativaLast Updated:July 18, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.